I'd say many here would still be very unhappy if Imugene went the way of Viralytics right now.
160% premium would be around 13.8c per share. Don't want to speak for everyone, but many long term investors here are waiting for $ not c.
I sure hope there is no TO on the horizon. A licensing deal for one platform or indication, fine, but don't sell the whole company for cheap.
Otherwise, happy for management to focus on clinical trials and IP for now.
Media Thread, page-15138
-
- There are more pages in this discussion • 508 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |